17 results
424B5
PNT
POINT Biopharma Global Inc.
14 Sep 22
Prospectus supplement for primary offering
4:12pm
or discourage an attempt to obtain control of POINT by means of a merger, tender offer, proxy contest or otherwise and thereby protect the continuity
424B5
PNT
POINT Biopharma Global Inc.
13 Sep 22
Prospectus supplement for primary offering
5:19pm
render more difficult or discourage an attempt to obtain control of POINT by means of a merger, tender offer, proxy contest or otherwise and thereby
424B3
PNT
POINT Biopharma Global Inc.
11 Jul 22
Prospectus supplement
4:32pm
or discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise and thereby protect
POS AM
PNT
POINT Biopharma Global Inc.
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
or discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise and thereby protect
S-3
PNT
POINT Biopharma Global Inc.
1 Jul 22
Shelf registration
4:13pm
to obtain control of POINT by means of a merger, tender offer, proxy contest or otherwise and thereby protect the continuity of management and possibly
424B3
e99nx
31 Mar 22
Prospectus supplement
11:42am
POS AM
buj40vypditqqa1
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
6diwkjgk
5 Aug 21
Prospectus supplement
4:26pm
10-K
EX-4.2
aya3bh8ixlugjga y4mm
5 Mar 21
Annual report
8:13am
424B4
2qd4rt3emdc c1uxhn
9 Jul 20
Prospectus supplement with pricing info
4:46pm
S-1
pdf46ef7
15 Jun 20
IPO registration
5:28pm
DRS
ti3 cz3dch
14 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next